MRI for Adrenal Nodule Evaluation: Contrast Not Always Required
Contrast is not required for initial MRI evaluation of adrenal nodules—chemical shift imaging (CSI) sequences without contrast can diagnose most adenomas by detecting intracellular lipid. However, T2-weighted and postcontrast sequences help further characterize indeterminate lesions that remain undiagnosed after CSI 1.
Primary MRI Sequences: Non-Contrast Chemical Shift Imaging
The cornerstone of adrenal MRI is chemical shift imaging (CSI), which requires no contrast administration. CSI uses specialized T1-weighted sequences (in-phase and opposed-phase) to detect intracellular lipid content 1:
- Adenomas demonstrate signal loss on opposed-phase versus in-phase images due to intracellular fat
- Visual comparison of these sequences is as reliable as quantitative measurements 1
- CSI is most effective for lesions with noncontrast CT attenuation between 10-20 HU; effectiveness decreases for 20-30 HU lesions and is unlikely to help above 30 HU 1
When to Add Contrast: Indeterminate Lesions
T2-weighted and postcontrast MRI sequences are reserved for lesions not diagnosed as benign on CSI 1. While these contrast-enhanced sequences don't definitively distinguish lipid-poor adenomas from malignancy, they reveal characteristic features:
- Pheochromocytomas show T2 hyperintense signal 1
- Areas of cystic change or hemorrhage are better delineated 1
- Dynamic contrast enhancement patterns differ between adenomas and malignant masses 2, 3
Clinical Algorithm
For most adrenal nodules, start with non-contrast MRI including CSI:
- If CSI shows homogeneous signal loss → Diagnosis: adenoma (no contrast needed) 1
- If CSI is indeterminate or shows no signal loss → Add T2-weighted and postcontrast sequences 1
- For suspected pheochromocytoma → T2-weighted imaging is particularly valuable (may or may not need contrast) 1
Guideline Recommendations
Recent endocrine guidelines recommend MRI over contrast-enhanced CT when additional imaging is needed after noncontrast CT 1. This reflects:
- Declining accuracy of CT washout calculations 1
- Pheochromocytomas (up to 35%) and certain metastases can mimic adenoma washout patterns 1
- MRI offers superior tissue characterization without radiation 1
Special Populations Where MRI (Often Without Contrast) Is Preferred
- Genetic predisposition requiring serial screening (e.g., familial pheochromocytoma syndromes) to avoid radiation 1
- Pediatric or pregnant patients 1
- Locally advanced tumors where soft tissue contrast resolution helps delineate extra-adrenal disease 1
Key Pitfalls
- Heterogeneous signal loss on CSI is controversial—minute amounts of microscopic fat can occur in pheochromocytoma, adrenocortical carcinoma, and some metastases 4
- Macroscopic fat (seen in myelolipomas) shows different imaging characteristics than intracellular lipid: high T1 signal with signal loss on fat-saturated sequences 1
- Always exclude pheochromocytoma biochemically before any biopsy, regardless of imaging findings 4
Bottom Line
Begin with non-contrast MRI using chemical shift imaging for most adrenal nodules. Reserve contrast administration for lesions that remain indeterminate after CSI, particularly when evaluating for pheochromocytoma (T2 hyperintensity) or assessing lipid-poor adenomas versus malignancy. This approach maximizes diagnostic yield while minimizing contrast exposure 1.